Adial Pharmaceuticals
ADIL • NASDAQ • Stock Fundamentals
Adial Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Cary John Claiborne, with a market cap of $6.4M.
Market Cap$6.4M
Employees7.0
CEOCary John Claiborne
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 8, 2026 · 1 month 5 days agoQ1 2026
View reportNext EarningsAug 12, 2026 · in 2 monthsQ2 2026
Financials
Based on Q1 2026 filing
Adial Pharmaceuticals FAQ
Common questions about Adial Pharmaceuticals
Adial Pharmaceuticals (ADIL) has a market capitalization of $6.4M and trades on NASDAQ.
Adial Pharmaceuticals has approximately 7 employees.